Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04177225 · ClinicalTrials.gov registry record

Effect of Diastolic Dysfunction on Dynamic Cardiac Monitors

A clinical trial, sponsored by University of California, Davis.

Completed
Registry status
120
Enrollment target

NCT04177225: Completed study, sponsored by University of California, Davis.

NCT04177225 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04177225 has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
120 participants
Enrollment target

Study Summary

This investigator initiated, prospective, observational, single-center study is designed to assess whether dynamic monitors of cardiac function such as stroke volume variation (SVV) that have been shown to predict volume responsiveness differ in clinical utility between patients with and without diastolic dysfunction.

Primary Outcome

The sensitivity of SVV as a predictor of the change in cardiac output in response to IV fluid administration will be determined by analysis of the Receiver Operator Characteristic (ROC) curves for each of the patient groups as distinguished by their pre-induction assessment of diastolic left ventricular function

Interventions

  • PROCEDURE Trans thoracic Ultrasound Examination
  • OTHER Intravenous fluid administration

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2019-02-07
Est. Completion 2021-02-01
University of California, Davis

657 total trials

What the finished NCT04177225 record still lists

NCT04177225 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 2 interventions - of which Trans thoracic Ultrasound Examination is the first listed.

NCT04177225 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04177225 about?

NCT04177225 is a clinical study titled "Effect of Diastolic Dysfunction on Dynamic Cardiac Monitors". This investigator initiated, prospective, observational, single-center study is designed to assess whether dynamic monitors of cardiac function such as stroke volume variation (SVV) that have been shown to predict volume responsiveness differ in clinical utility between patients with and without dia...

What is the current status of trial NCT04177225?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2019-02-07. Estimated completion is 2021-02-01.

What interventions are being tested in trial NCT04177225?

The interventions under investigation include: Trans thoracic Ultrasound Examination (PROCEDURE), Intravenous fluid administration (OTHER).

Who is sponsoring clinical trial NCT04177225?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04177225, the US trial registry maintained by the National Library of Medicine. NCT04177225 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.